Abstract
In a preface to a symposium concerning economics, Professor Norman Sartorius1 stated: “At least three questions seem to beset the health care system of the world today a) How much money are we spending on health care, b) Could we get as much or more effect for less money and c) Who should be paying for health care.” As these three questions are so crucial in today’s world, it seems to be important to be able to justify the strategies we use in the health care system by means of realistic cost effective analysis. It is also important that we try to describe the costs and the benefits in a similar language so that comparisons can be made. It is e.g. not easy to compare the costs for the Selective Serotonin Reuptake Inhibitors (SSRIs) with the 3 point difference on the Hamilton Depression Scale (HAM-D) usually found between the SSRI group and the placebo group in studies where SSRIs are compared to placebo in 6-8 week long trials.2 However, the language of economics, borrowed from the economic sciences is not optimal when used in the health care setting. As pointed out by Professor Sartorius1 it is often difficult to decide which expenses concern health care. It is difficult to know whether an expense was related to treatment of disease, improvement of health or improvement of quality of life. Furthermore, at present there is little agreement about the minimum, optimum or (excessive) maximum of care necessary for a single patient. Another problem that arises is that of accounting for the amount of effort that patients themselves and their families invest. Finally, the ways of measuring the indirect costs of diseases are at present unsatisfactory and have met limited acceptance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
N. Sartorius. 1998, Preface, Br. J. Psychiatry 173, Suppl. 36:3.
L. von Knorring, and K. Bingefors, 1998, Resistant depression: the need for better antidepressants, in: Antidepressant therapy at the dawn of the third millenium, (M. Briley, and S. Montgomery, eds.), pp. 319–332, Martin Dunitz Ltd, London.
C. Palmer, D. Revicki, M. Halpern, and E. Hatziandreu, 1995,The cost of suicide and suicide attempts in the United States, Clin. Neuropharmacol. 18:S25–S33.
W. Rutz, P. Carlsson, L. von Knorring, and J. Wálinder, 1992, Cost-benefit analysis of an educational program for general practitioners by the Swedish Committee for the Prevention and Treatment of Depression, Acta Psychiatr. Scand. 85:457–464.
B. Runeson, and D. Wasserman, 1994, Management of suicide attempters: what are the routines and the costs?, Acta Psychiatr. Scand. 90:222–228.
Z. Rihmer, 1996, Strategies of suicide prevention: Focus on health care. J. Aff. Dis. 39:83–91.
C. Rich, D. Young, and R. Fowler, 1986, San Diego suicide study 1. Young vs old subjects, Arch. Gen. Psychiatry 1986:577–582.
E. Isometsä, M. Henriksson, H. Aro, M. Heikkinen, K. Kouppasalmi, and J. Lönnqvist, 1994, Suicide in major depression, Am. J. Psychiatry 151:530–536.
M. Arato, E. Demeter, Z. Rihmer, and E. Somogyi, 1988, Retrospective psychiatric assessment of 200 suicides in Budapest, Acta Psychiatr. Scand. 77:454–456.
A. Cheng, 1995, Mental illness and suicide, Arch. Gen. Psychiatry 52:594–603.
B. Barraclough, J. Bunch, B. Nelson, and P. Sainsbury, 1974, A hundred cases of suicide, Br. J. Psychiatry 125:355–373.
G. Olsson, 1998, Adolescent depression. Epidemiology, Nosology, Life Stress, and Social Network, Doctoral Dissertation from the Faculty of Medicine, No. 770, Uppsala University Library, Uppsala.
N. Ryan, D. Williamson, S. lyengar, H. Orvaschel, T. Reich, R. Dahl, and J. Puigh-Antich, 1992, A Secular Increase in Child and Adolescent onset Affective Disorders, J. Am. Acad. Child Adol. Psychiatry 31:600–605.
P. Joyce, 1984, Age of onset in bipolar affective disorder and misdiagnosis as schizophrenia, Psychol. Med. 14:145–149.
G. Olsson, and A.L. von Knorring, 1997, Beck’s Depression Inventory as a swcreening instrument for adolescent depression in Sweden: gender differences, Acta Psychiatr. Scand. 95:277–282.
G. Olsson, and A.L. von Knorring, 1997, Depression among Swedish adolescents measured by the self-rating scale Center for Epidemiological Studies—Depression Child (CES-DC), Eur. Child Adol. Psychiatry 6:81–87.
K. Bingefors, D. Isacson, L. von Knorring, and B. Smedby, 1995, Prescription drug and health care use among Swedish patients treated with antidepressants, Ann. Pharmacother. 29:566–572.
J. Canals, E. Domenech, G. Carbajo, and J. Blade. 1997, Prevalence of DSM-III-R and ICD-10 psychiatric disorders in a Spanish population of 18-year-olds, Acta Psychiatr Scand. 96:287–294.
American Psychiatric Association, 1987, Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised, APA, Washington DC.
World Health Organization, 1993, The lCD-10 Classification of Mental and Behaioural Disorders: Diagnostic Criteria for Research, WHO, Geneva.
J. Gorman, 1996/1997, Comorbid depression and anxiety spectrum disorders, Depression and Anxiety 4:160–168.
J. Rodney, N. Prior, B. Cooper, M. Theodoros, J. Browning, B. Steinberg, and L. Evans, 1997, The comorbidity of anxiety and depression, Aust. N.Z.J. Psychiatry 31:700–703.
C. Sherbourne, and K. Wells, 1997, Course of depression in patients with comorbid anxiety disorders, J. Aff. Dis. 43:245–250.
J. Angst, 1997, Depression and anxiety: Implications for nosology, course, and treatment, J. Clin. Psychiatry 58:3–5.
K. Kendler, C. Davis, and R. Kessler, 1997, The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity survey: A family history study, Br. J. Psychiatry 170:541–548.
American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, DSM-IV, APA, Washington DC.
E. Corruble, D. Ginestet, and J. Guelfi, 1996, Comorbidity of personality disorders and unipolar major depression: A review, J. Aff. Dis. 37:157–170.
L. Ekselius, L. von Knorring, and G. Eberhard, 1997, A Double-Blind Multicenter Trial Comparing Sertraline and Citalopram in Patients with Major Depression Treated in General Practice, Int. Clin. P.sychopharmacol. 12:323–331.
L. Kiloh, J. Ball, and R. Garside, 1962, Prognostic factors in the treatment of depressive states with imipramine, Br. Med. J. 1:1225–1227.
B. Pfohl, D. Stangl, and M. Zimmerman, 1984, The implications of DSM-III disorders for patients with major depression, J. Aff Dis. 7:309–318.
D. Black, S. Bell, J. Hulbert, and A. Nasrallah, 1988, The importance of Axis II in patients with major depression, I Aff. Dis. 14:115–122.
J. Reich, 1990, Effect of DSM-III personality disorders on outcome of tricyclic antidepressant treated nonpsychotic outpatients with major or minor depressive disorders, Psychiatry Res. 32:175–181.
H. Akiskal, A. Bitar, V. Puzantian, T. Rosenthal, and P. Walker, 1978, The nosological status of neurotic depression, Arch. Gen. Psychiatry 35:756–766.
L. Thompson, D. Gallagher, and R. Czirr, 1988, Personality disorder and outcome in the treatment of late life depression, J. Ger. Psychiatry 21:133–150.
M. Ansseau, B. Troisfonatines, P. Papart, and R. von Frenckel, 1991, Compulsive personality as predictor of response to sertonergic antidepressants, Br. Med. J. 303:760–761.
M. Fava, E. Bouffides, J. Pava, M. McCarthy, R. Steingard, and J. Rosenbaum, 1994, Personality disorder comorbidity with major depression and response to fluoxetine treatment, Psychother. Psychosom. 62:160–167.
M. Fava, L. Uebelacker, J. Alpert, A. Nirenberg, J. Pava, and J. Rosenbaum, 1997, Major depressive subtypes and treatment response, Biol. Psychiatry 42:568–576.
D. Patience, R. McGuire, A. Scott, and C. Freeman, 1995, The Edinburgh primary care depression study: Personality disorder and outcome, Br. J. Psychiatry 167:324–330.
R. Chynoweth, J. Tonge, and J. Armstrong. 1980, Suicide in Brisbane—a retrospective psychosocial study, Aus. N.Z.J. Psychiatry 14:37–45.
A. Lesage, R. Boyer, F. Gruenberg, C. Vanier, R. Morissette, C. Menard-Buteau, and M. Loyer, 1994, Suicide and mental disorders: a case control study of young men, Am. J. Psychiatry 151:1063–1068.
A. Cheng, and A. Mann, Chan-KA, 1997, Personality disorder and suicide: A case-control study, Br. J. Psychiatry 170:441–446.
P. Silverstone, 1996, Prevalence of psychiatric disorders in psychiatric inpatients, J. Nerv. Ment Dis. 1996:43–51.
G. Keitner, C. Ryan, I. Miller, R. Kohn, and N. Epstein, 1991, 12-month outcome of patients with major depression and comorbid psychiatric or medical illness (compound depression), Am. J. Psychiatry 148:45–50.
R. Gregory, D. Jimerson, B. Walton, J. Daley, and R. Paulsen, 1992, Pharmacotherapy of depression in the medically ill: Directions for future research, Gen. Hasp. Psychiatry 14:36–42.
R. Widmer, and R. Cadoret, 1983, Depression: The great imitator in family practice., J. Fam. pract 17:485–505.
G. Wilkinson, N. Smeeton, D. Skuse, and J. Fry, 1988, Consultation for physical illnesses by patients diagnosed and treated for psychiatric disorders by general practitioner: 20 year follow up study, Br. Med. J. 297:776–778.
K. Bingefors, D. Isacson, L. von Knorring, B. Smedby, L. Ekselius, and L. Kupper, 1996, Antidepressant-treated Patients in Ambulatory care. Long-term use of Non-psychotropic and Psychotropic Drugs, Br. J. Psychiatry 168:292–298.
A. Sims, 1988, The mortality associated with ddepression, Int Clin Psychopharm 3:1–13.
R. Carney, M. Rich, K. Freedland, J. Saini, A. deVelde, and C. Simeone, 1988, Major depressive disorder predicts cardiac events in patietns with coronary artery disease, Psychosom. Med. 50:627–633.
N. Frasure-Smith, F. Lesperanee, and M. Talajic, 1993, Depression following myocardial infarction. Impact on 6-month survival, JAMA 270:1819–1825.
C. Perris, 1966, A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses X. Mortality, suicide, and life-cycles, Acta Psychiatr. Scand. 42:72–183.
C. Perris, 1966, A Study of Bipolar (Manic-Depressive) and Recurrent Depressive Psychoses, Acta Psychiatr. Scand. Suppl.194.
M. Bruce, P. Leaf, G. Rozal, L. Florio, and R. Hoff, 1994, Psychiatric status and 9-year mortality data in the New haven Epidemiological Catchment Area Study, Am. J. Psychiatry 151:716–721.
K. Bingefors, D. Isacson, L. von Knorring, B. Smedby, and K. Wicknertz, 1996, Antidepressant-Treated Patients in Ambulatory Care. Mortality During a Nine-Year Period after First Treatment, Br. J. Psychiatry 169:647–654.
E. Harris, and B. Barraelough, 1998, Excess mortality of mental disorder, Br J Psychiatry 173:11–53.
E Greenberg, L. Stiglin, S. Finkelstein, and E. Berndt, 1993, The Economic Burden of Depression in 1990, J. Clin. Psychiatry 54:405–418.
T. Croghan, R. Obenchain, and W. Crown, 1998, What Does Treatment of Depression Really Cost? Although treating a patient with depression is expensive, the bulk of costs is for care of accompanying illnesses, Data Watch 17: 98–208.
A. Hornblow, 1986, The Evolution and Effectiveness of Telephone Counseling Services, Hasp. Comm. Psychiatry 37:731–733.
C. Jennings. 1978, Have the Samaritans lowered the suicide rate? A constrolled study, Psychol. Med. 8:413–422.
A. Tylee, 1996, DEPRES (Depression Patient Research in European Society): The patient perspective of depression. Paper presented at the 8th Congress of European Psychiatrists, London.
G. Eberhard, G. Holmberg, A.-L. von Knorring, L. von Knorring, W. Rutz, B. Wistedt, J. Wâlinder, and A. Aberg-Wistedt, 1986, Evaluation of postgraduate medical education given by the Swedish PTDCommittee, Nord. J. Psychiatry 40:185–192.
W. Rutz, L. von Knorring, and J. Walinder, 1992, Long-term effects of an educational program for general practitioners given by the Swedish Committee for Prevention and Treatment of Depression, Acta Psychiatr. Scand. 85: 83–88.
W. Rutz, L. von Knorring, H. Pihlgren, Z. Rihmer, and J. Wálinder, 1995, An educational project on depression and its consequences: is frequency of major depression among Swedish men underrated, resulting in high suicidality?, Prim. Care Psychiatry 1:59–63.
W. Rutz, J. Wálinder, G. Eberhard, G. Holmberg, A.-L. von Knorring, L. von Knorring, B. Wistedt, and A. Aberg-Wistedt, 1989, An educational program on depressive disorders for general practitioners on Gotland: Background and evaluation, Acta Psychiatr. Scand. 79:19–26.
W. Rutz, L. von Knorring, J. Wálinder, and B. Wistedt, 1990, Effect of an educational program for general practitioners on Gotland on the pattern of prescription of psychotropic drugs, Acta Psychiatr. Scand. 82:399–403.
Z. Rihmer, W Rutz, and H. Pihlgren, 1995, Depression and suicide on Gotland An intensive study of all suicides before and after a depression-training programme for general practitioners, J. Aff. Dis. 35:47–152.
Z. Rihmer, W. Rutz, and J. Barsi, 1993, Suicide rate, prevalence of diagnosed depression, and prevalence of working physicians in Hungary, Acta Psychiatr. Scand. 88:391–394.
J. Lave, R. Frank, H. Schulberg, and M. Kamlet, 1998, Cost effectiveness of Treatment for Major Depression in Primary Care, Arch. Gen. Psychiatry 55:645–651.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
von Knorring, L., Bingefors, K., Ekselius, L., von Knorring, AL., Olsson, G. (1999). Cost Effectiveness in the Prevention of Suicide. In: Guimón, J., Sartorius, N. (eds) Manage or Perish?. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4147-9_35
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4147-9_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6860-1
Online ISBN: 978-1-4615-4147-9
eBook Packages: Springer Book Archive